Synopsis
Why Should Minorities Participate in Clinical Trials?
In this powerful and insightful book, Dr. Chardae Rodgers-Gamble shines a spotlight on one of the most critical issues in modern healthcare—health disparities and the lack of representation in clinical trials. Drawing from her extensive expertise in clinical research, Dr. Rodgers-Gamble explores the profound impact that diversity has on the advancement of medical knowledge, treatment effectiveness, and community health.
Through compelling narratives, real-life examples, and evidence-based insights, this book examines barriers to participation, the historical roots of mistrust in the healthcare system, and the transformative potential of inclusive research practices. With clarity and compassion, it outlines the steps needed to ensure equitable access to groundbreaking treatments and emphasizes the importance of cultural competence and trust in fostering meaningful connections between researchers and diverse communities.
'Why Should Minorities Participate in Clinical Trials?' is not just a call to action but a roadmap to creating a more inclusive and equitable future in healthcare—one where every voice is heard, every story matters, and no one is left behind.
For anyone passionate about equity in medicine, this book offers an enlightening perspective on the power of diversity to shape the future of healthcare for all.
About the Author:
Dr. Chardae Rodgers-Gamble, CEO of CR Clinical, is a trailblazer in clinical research, recognized as one of the “20 Most Inspiring Women Leaders of 2022” and a “Trailblazer Woman Leader of 2023.” With over 13 years of industry experience, she is dedicated to transforming healthcare through innovation, advocacy, and education.
Visit www.crclinical.com to learn more about Dr. Rodgers-Gamble’s work and mission.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Why Should Minorities Participate in Clinical Trials?
Image d'archives
Why Should Minorities Participate in Clinical Trials?
impression à la demandeVendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798306832098
Acheter neuf
EUR 18,93
Expédition à EUR 3,77
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Why Should Minorities Participate in Clinical Trials?
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9798306832098_new
Acheter neuf
EUR 17,62
Expédition à EUR 13,73
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Why Should Minorities Participate in Clinical Trials? (Paperback)
impression à la demandeVendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. Why Should Minorities Participate in Clinical Trials?In this powerful and insightful book, Dr. Chardae Rodgers-Gamble shines a spotlight on one of the most critical issues in modern healthcare-health disparities and the lack of representation in clinical trials. Drawing from her extensive expertise in clinical research, Dr. Rodgers-Gamble explores the profound impact that diversity has on the advancement of medical knowledge, treatment effectiveness, and community health.Through compelling narratives, real-life examples, and evidence-based insights, this book examines barriers to participation, the historical roots of mistrust in the healthcare system, and the transformative potential of inclusive research practices. With clarity and compassion, it outlines the steps needed to ensure equitable access to groundbreaking treatments and emphasizes the importance of cultural competence and trust in fostering meaningful connections between researchers and diverse communities.'Why Should Minorities Participate in Clinical Trials?' is not just a call to action but a roadmap to creating a more inclusive and equitable future in healthcare-one where every voice is heard, every story matters, and no one is left behind.For anyone passionate about equity in medicine, this book offers an enlightening perspective on the power of diversity to shape the future of healthcare for all.About the Author: Dr. Chardae Rodgers-Gamble, CEO of CR Clinical, is a trailblazer in clinical research, recognized as one of the "20 Most Inspiring Women Leaders of 2022" and a "Trailblazer Woman Leader of 2023." With over 13 years of industry experience, she is dedicated to transforming healthcare through innovation, advocacy, and education. to learn more about Dr. Rodgers-Gamble's work and mission. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798306832098
Acheter neuf
EUR 23,01
Expédition à EUR 42,41
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)